Strata Critical Medical, Inc.: updates and filings

SRTANASDAQIndustrials · Transportation Services

Price

$4.96

November 18, 2026Market cap $431M

What Ploutos Investor adds for Strata Critical Medical

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from FY2019
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 77 daysAround Feb 4, 2027 · for Q4 2026

last Nov 3, 2026next Feb 4, 2027

A rough estimate from when it has reported before, which has varied. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Mar 3, 2026 latest annualNov 3, 2026 latest quarterly
  • Nov 3, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Nov 3, 2026Results of operations
    Form8-K
  • Oct 15, 2026Over-5% holder statement (active)
    FormSCHEDULE 13D
  • Aug 20, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 4, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 4, 2026Results of operations
    Form8-K
  • Jul 8, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jun 17, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Jun 3, 2026Shareholder vote
    Form8-K
  • May 8, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • May 6, 2026One of its securities removed from an exchange (usually a matured note)
    Form25-NSE
  • May 6, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • May 6, 2026Results of operations
    Form8-K
  • Apr 30, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Apr 16, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • Apr 14, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 14, 2026Annual meeting proxy statement
    FormDEF 14A
  • Apr 8, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • Apr 7, 2026Over-5% holder statement (active)
    FormSCHEDULE 13D
  • Mar 3, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Mar 3, 2026Results of operations
    Form8-K
  • Feb 5, 2026Material agreement entered, Regulation FD disclosure
    Form8-K
  • Jan 21, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Dec 3, 2025Officer or director change, Regulation FD disclosure
    Form8-K
  • Dec 2, 2025Acquisition or disposal of assets (amendment)
    Form8-K/A

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jun 26, 2019.

The full analysis

What do Strata Critical Medical's filings show?

The filings are where every one of Strata Critical Medical's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.